Cleveland BioLabs
CBLI
$3.17
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)
Categories
Market capitalization of Cleveland BioLabs (CBLI)
Market cap: $49.06 Million
As of April 2024 Cleveland BioLabs has a market cap of $49.06 Million. This makes Cleveland BioLabs the world's 7738th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cleveland BioLabs from 2006 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $49.06 M | 0% |
| 2021 | $49.06 M | 9.27% |
| 2020 | $44.9 M | 560.24% |
| 2019 | $6.8 M | -40.4% |
| 2018 | $11.41 M | -74.77% |
| 2017 | $45.23 M | 189.91% |
| 2016 | $15.6 M | -59.31% |
| 2015 | $38.34 M | 135.37% |
| 2014 | $16.29 M | -69.18% |
| 2013 | $52.86 M | -11.14% |
| 2012 | $59.49 M | -41.42% |
| 2011 | $0.10 B | -51.42% |
| 2010 | $0.20 B | 212.66% |
| 2009 | $66.87 M | 129.24% |
| 2008 | $29.17 M | -74.3% |
| 2007 | $0.11 B | 90.44% |
| 2006 | $59.6 M |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $202.12 B | 411,823.30% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $689.18 B | 1,404,440.89% | 🇺🇸 USA |
 Amgen AMGN | $144.48 B | 294,366.11% | 🇺🇸 USA |
 Sanofi SNY | $123.22 B | 251,030.03% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $90.59 B | 184,533.48% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $83.58 B | 170,235.37% | 🇬🇧 UK |
 Soligenix SNGX | $6.08 M | -87.61% | 🇺🇸 USA |
 OPKO Health
OPK | $0.85 B | 1,632.96% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.9 M | -57.40% | 🇺🇸 USA |